Amprion is a pioneering brand in the field of brain disorder diagnostics, specializing in detecting misfolded proteins associated with various conditions. Their flagship product, the SYNTap Test, is a breakthrough diagnostic tool that helps doctors accurately diagnose synucleinopathies like Parkinson's disease, Lewy Body Dementia, Alzheimer's with Lewy Bodies, Minimal Cognitive Impairment with Lewy Bodies, and Multiple System Atrophy. By detecting the biomarker Synuclein, this test significantly improves diagnostic accuracy.

Amprion's cutting-edge platform has been recognized by reputable organizations such as the Michael J. Fox Foundation. Driven by a mission to advance the diagnosis of brain disorders, Amprion leverages its expertise in Prion Detection Science® to develop innovative biomarker testing solutions.

Their SYNTap Biomarker Test aids physicians worldwide in diagnosing these challenging conditions. Amprion continues to push the boundaries of scientific research, with plans to launch more biomarker tests in the future. Please note that this website is intended for healthcare professionals seeking informational purposes